US Stock MarketDetailed Quotes

IGC IGC Pharma

Watchlist
  • 0.4580
  • +0.0280+6.51%
Close Apr 26 16:00 ET
  • 0.4800
  • +0.0220+4.80%
Post 19:52 ET
30.60MMarket Cap-1761P/E (TTM)

IGC Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

IGC Pharma Earnings Date

Currency: USD

Period

Q3 FY2024 Earnings

--

Revenue(YoY)

204.00K

-38.55%
EPS(YoY)

-0.09

-125.00%
Analyst Rating

Buy

Mar 5, 2024

IGC Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 622.000K--
--2024/Q4-- / 193.000K--
--2024/Q3204.000K / 448.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 622.000K--
--2024/Q4-- / 193.000K--
--2024/Q3204.000K / 448.000K--

IGC Pharma Earnings Reports

  • IGC Pharma | 10-Q: Quarterly report

    Feb 14 18:00 ET

  • IGC Pharma: Q2 2024 Earnings Report

    Nov 9, 2023 17:15 ET

  • IGC Pharma | 10-Q: Q1 2024 Earnings Report

    Aug 10, 2023 16:10 ET

  • IGC Pharma | 10-K: FY2023 Annual Report

    Jul 7, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 5, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg